Kalvista Pharmaceuticals Inc
NASDAQ:KALV

Watchlist Manager
Kalvista Pharmaceuticals Inc Logo
Kalvista Pharmaceuticals Inc
NASDAQ:KALV
Watchlist
Price: 11.47 USD 5.04% Market Closed
Market Cap: 579.5m USD

Wall Street
Price Targets

KALV Price Targets Summary
Kalvista Pharmaceuticals Inc

Wall Street analysts forecast KALV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KALV is 32.41 USD with a low forecast of 20.2 USD and a high forecast of 42 USD.

Lowest
Price Target
20.2 USD
76% Upside
Average
Price Target
32.41 USD
183% Upside
Highest
Price Target
42 USD
266% Upside
Kalvista Pharmaceuticals Inc Competitors:
Price Targets
BCRX
BioCryst Pharmaceuticals Inc
159% Upside
REGN
Regeneron Pharmaceuticals Inc
28% Upside
YMAB
Y-mAbs Therapeutics Inc
5% Downside
RYTM
Rhythm Pharmaceuticals Inc
20% Upside
GNFT
Genfit SA
161% Upside
AZT
Arcticzymes Technologies ASA
5% Upside
301207
Hualan Biological Bacterin Inc
14% Upside
ADMA
ADMA Biologics Inc
107% Upside

Revenue
Forecast

Revenue Estimate
Kalvista Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
13%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Kalvista Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Kalvista Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-61%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KALV's stock price target?
Price Target
32.41 USD

According to Wall Street analysts, the average 1-year price target for KALV is 32.41 USD with a low forecast of 20.2 USD and a high forecast of 42 USD.

Back to Top